The Effects Of Covid-19 On Pharmaceutical Production Worldwide

European Union health ministers raised concerns over the potential for drug shortages if the COVID-19 outbreak continues to keep China in a near lockdown.

Euronews reported an emergency meeting in Brussels. Agnes Buzyn from France talked about ‘breaks in supply chains,’’ while Finland’s Minister said COVID-19 could increase what is already an ongoing problem in Europe.  

Six percent of the EU’s medicinal and pharmaceutical imports came from China in 2018, according to Eurostat, for the U.S. this is thirteen percent of pharmaceutical imports.

China also produces some of the API’s which other countries use to manufacture painkillers, diabetes drugs and antibiotics. For example, India is the world’s largest generic drug exporter, but get its sources from China. The problem however is bigger than the import of finished products.

Certain countries like Luxembourg are vulnerable. It has no pharmaceutical industry and imports all of its drugs and medical equipment.

As a result of the COVID-19 outbreak, many countries will have problems producing their medicines., especially those which import all their API’s from China or India.